Literature DB >> 2393942

Trapping and measurement of short-lived alkylating agents in a recirculating flow system.

A R Mattocks1, R Jukes.   

Abstract

A procedure has been developed for estimating the survival time of short-lived alkylating agents in a flow system at physiological temperature and pH. The system simulated the slow release into the bloodstream of a reactive compound formed in the liver. A solution of the reactive compound was injected slowly into a fast stream of aqueous fluid and immediately mixed. After a delay (up to 1 min) determined by a length of tube, during which hydrolysis took place, the surviving reactive compound was trapped on a column of immobilized thiol (thiol-Sepharose), and the fluid was recirculated via a reservoir. The system was used to study the hydrolysis of the pyrrolizidine alkaloid metabolites dehydromonocrotaline, dehydro-anacrotine and dehydroretrorsine. The S-bound pyrrolic moiety in the trap was measured colorimetrically and hydrolysis rates were estimated after a series of 1-h runs with different delay times. Hydrolysis of dehydroretrorsine was very rapid, whereas the hydrolysis of dehydromonocrotaline and dehydro-anacrotine fitted biphasic first-order reactions, with a faster first phase. By isolating and identifying the trapped products from dehydromoncrotaline it was shown that the two phases involved hydrolysis of the 7- and 9-ester groups, respectively. The results supported the view that a proportion of the reactive metabolites from the alkaloids monocrotaline and anacrotine would be able to survive long enough to be transported from the liver to the lungs of a rat. The flow system would be applicable to the study of other types of short-lived metabolites.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2393942     DOI: 10.1016/0009-2797(90)90031-h

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  8 in total

1.  Physicochemical and metabolic basis for the differing neurotoxicity of the pyrrolizidine alkaloids, trichodesmine and monocrotaline.

Authors:  R J Huxtable; C C Yan; S Wild; S Maxwell; R Cooper
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

2.  Hepatic cytochrome P450s play a major role in monocrotaline-induced renal toxicity in mice.

Authors:  Jun Yao; Cheng-gang Li; Li-kun Gong; Chen-chen Feng; Chun-zhu Li; Man Gao; Yang Luan; Xin-ming Qi; Jin Ren
Journal:  Acta Pharmacol Sin       Date:  2013-12-23       Impact factor: 6.150

3.  Senescent endothelial progenitor cells from dogs with pulmonary arterial hypertension: a before-after self-controlled study.

Authors:  Liang Xia; Jun-hui Zhu; Fu-yu Qiu; Ying Yang; Xu-dong Xie; Xing-xiang Wang; Jun-zhu Chen; Guo-sheng Fu
Journal:  J Physiol Sci       Date:  2009-07-28       Impact factor: 2.781

4.  Low dose monocrotaline causes a selective pulmonary vascular lesion in male and female pneumonectomized rats.

Authors:  Daniel J Lachant; David F Meoli; Deborah Haight; Jason A Lyons; Robert F Swarthout; R James White
Journal:  Exp Lung Res       Date:  2018-01-30       Impact factor: 2.459

5.  Lung injury induced by pyrrolizidine alkaloids depends on metabolism by hepatic cytochrome P450s and blood transport of reactive metabolites.

Authors:  Yisheng He; Wei Lian; Liang Ding; Xiaoyu Fan; Jiang Ma; Qing-Yu Zhang; Xinxin Ding; Ge Lin
Journal:  Arch Toxicol       Date:  2020-10-08       Impact factor: 5.153

6.  The key role of gut-liver axis in pyrrolizidine alkaloid-induced hepatotoxicity and enterotoxicity.

Authors:  Yisheng He; Jiang Ma; Xiaoyu Fan; Liang Ding; Xinxin Ding; Qing-Yu Zhang; Ge Lin
Journal:  Acta Pharm Sin B       Date:  2021-07-21       Impact factor: 11.413

7.  Structure-Dependent Toxicokinetics of Selected Pyrrolizidine Alkaloids In Vitro.

Authors:  Julia Buchmueller; Florian Kaltner; Christoph Gottschalk; Maria Maares; Albert Braeuning; Stefanie Hessel-Pras
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

Review 8.  DNA Damage and Pulmonary Hypertension.

Authors:  Benoît Ranchoux; Jolyane Meloche; Roxane Paulin; Olivier Boucherat; Steeve Provencher; Sébastien Bonnet
Journal:  Int J Mol Sci       Date:  2016-06-22       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.